Addendum to Commission A14-05 (Sofosbuvir) [Internet].

On 13 June 2014 the Federal Joint Committee (G-BA) commissioned the Institute for Quality and Efficiency in Health Care (IQWiG) to conduct a supplementary assessment for Commission A14-05 (benefit assessment of sofosbuvir).

http://ift.tt/2sje37A